Berkeley Lights Inc (NASDAQ: BLI) is trading lower Thursday after the company announced a CEO transition and reported preliminary financial results. Multiple analyst firms also downgraded the stock following the news.
Why is Berkeley Lights Inc (Bli) stock trading lower Thursday?
Sep 16, 2021 · For the second day in a row, biotech stock Berkeley Lights ( BLI -5.21% ) suffered a big investor sell-off, falling by almost 12% on Thursday. Even though an …
Is Berkely lights (BLI) a fraud?
Aug 11, 2021 · Investor sentiment was dimming notably on Berkeley Lights (NASDAQ: BLI) Wednesday, with the stock falling by over 9%. This followed the cell biology company's double whiff on Q2 earnings.
What is Berkeley lights and should you invest in it?
Jan 06, 2022 · Berkeley Lights Inc (NASDAQ: BLI) is trading lower Thursday after the company announced a CEO transition and reported preliminary financial results. Multiple analyst firms also downgraded the ...
Will Berkeley lights'revenue grow 30% in 2022?
Jan 07, 2022 · Berkeley Lights Inc (NASDAQ: BLI) is trading lower Thursday after the company announced a CEO transition and reported preliminary financial results. Multiple analyst firms also downgraded the stock...
Are Berkeley lights good buy?
Valuation metrics show that Berkeley Lights, Inc. may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors. The financial health and growth prospects of BLI, demonstrate its potential to underperform the market.
Will Berkeley lights stock go up?
Stock Price Forecast The 5 analysts offering 12-month price forecasts for Berkeley Lights Inc have a median target of 14.00, with a high estimate of 26.00 and a low estimate of 12.00. The median estimate represents a +135.69% increase from the last price of 5.94.
What to do if a stock keeps dropping?
If you're going to invest in stocks, you need to have a plan for when your stock's price falls.Revisit Your Investment Plan. Your stock's price will likely rise and fall to some degree during every market cycle, sometimes within a few moments. ... Buy More Shares. ... Take Your Losses. ... Re-Balance Your Portfolio.
Is BLI a buy?
(NASDAQ:BLI) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's no better way to get these firms' immense resources and analytical capabilities working for us than to follow their lead into their best ideas.Dec 10, 2020
What does Berkeley Light do?
About us. Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers.
How many employees does Berkeley lights have?
Company Growth (employees)Employees (est.) (Aug 2020)208(+2%)Job Openings102Website Visits (Jan 2022)15.9 kRevenue (FY, 2019)$56.7 M(+82%)Cybersecurity ratingDMore
Why is Block stock dropping?
The digital payment company's stock has been on a decline as part of a rotation out of growth stocks amid concerns of Fed rate hikes. The company formerly known as Square is down about 31% since announcing its corporate entity name change to Block, on Dec. 1 of last year.Jan 14, 2022
Why are stocks crashing?
Stock market crashes are often the result of several economic factors, including speculation, panic selling, and/or economic bubbles, and they may occur amid the fallout of an economic crisis or major catastrophic event.Feb 28, 2022
Should I buy stocks when they are low or high?
Stock market mentors often advise new traders to “buy low, sell high.” However, as most observers know, high prices tend to lead to more buying. Conversely, low stock prices tend to scare off rather than attract buyers.Feb 9, 2019
Is Berkeley a buy?
The Berkeley Group has received a consensus rating of Hold. The company's average rating score is 2.44, and is based on 5 buy ratings, 3 hold ratings, and 1 sell rating.
What happened
For the second day in a row, biotech stock Berkeley Lights ( BLI 2.67% ) suffered a big investor sell-off, falling by almost 12% on Thursday. Even though an analyst tracking the stock issued a bullish new research note on the company, it continued to experience the fallout from a sharply worded tweet storm delivered by a short seller.
So what
Scorpion Capital's six-tweet thread was published early on Wednesday, and it accused Berkeley Lights of "fleecing" both its customers and investors of its recent IPO.
Now what
Unfortunately for Berkeley Lights, neither update seems to be convincing the market that the stock is a safe buy. What might be affecting the sentiment is the company's lack of official reaction to Scorpion's charges; this could at least somewhat calm investor nerves.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
About Activist Short Selling
Shorting a stock means you’re betting it will fall. If you short a stock, then publish a report telling the world it’s shite, that’s an apparent conflict of interest. Consequently, you’d better be damn sure what you’re saying is truthful and have the legal resources to defend yourself regardless.
The Scorpion Capital Report on Berkeley Lights
The report is an absolute beast, so let’s try and separate it into parts.
Should We Sell Berkeley Lights?
Most readers probably don’t realize just how risk averse we actually are. Across the total sum of assets we’re managing right now, 21% is allocated to our tech portfolio. Of that, around 24% is in cash. That means our total exposure to tech stocks right now sits at 17.5% of total assets.
Conclusion
We’ve consumed a meaningful amount of time poring over Berkeley Lights, from before they decided to IPO until today. Every time the share price fell off a cliff, we quickly moved to research why. It’s the sort of investment that wastes a lot of time, and it seems that will continue to get worse.
What happened
Investor sentiment was dimming notably on Berkeley Lights (NASDAQ: BLI) Wednesday, with the stock falling by over 9%. This followed the cell biology company's double whiff on Q2 earnings.
So what
Wednesday morning Berkeley Lights revealed that for the quarter, it booked revenue of $19.25 million, a near-doubling of the $10.57 million it made in Q2 2020. Yet net loss worsened across that period, deepening to $18.2 million ($0.27 per share) from the year-ago result of $12.4 million.
Now what
Berkeley Lights expects that this strategy will keep the revenue growth motor humming. The company reaffirmed its top-line guidance for full-year 2021 of $90 million to $100 million, which would represent growth of at least 40% over the 2020 tally. It did not proffer any profitability estimates.
How long has Berkeley Lights been public?
Berkeley Lights has only been a public company for around 7 months and in that time frame the company shot up like a shooting star and lately has been falling like big ole humpty dumpty.
How much will cell therapy grow in 2024?
Cell therapy and synthetic biology are expected to grow at 68% and 29% per year respectively through 2024. Berkeley is by no means the only game in town as cell therapies have been around for some time now, but from all the information I can find, Berkeley simply crushes the previous standards. Source: Berkeley Lights.
What is Berkeley Lights?
Berkeley Lights is a digital cell biology company that focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products.
Is Berkeley Lights a biotech company?
Berkeley Lights operates in a high growth and rapidly expanding area of biotech. The company looks to continue to build on its first mover advantage. The company is now trading below the price reached after the IPO in July as it is currently a victim of the carnage in growth stocks.
Why Is Berkeley Lights Stock Falling?
- Why do racoons wash their food before they eat? Why do tweakers always drive cars with broken doors? Why do stocks fall for no reason? It’s tough to find answers to these questions, but for stocks, you can check the usual suspects. Any 8-K filings with the SEC? Any banter over at Seeki…
The Single-Cell Landscape
- Single Cell Genomics (SCG) is about isolating a single cell from a group of cells to study it, measure it, and sequence it. It’s an emerging field that’s only taken off in the past three years. That’s according to a piece by a consulting firm called DeciBio titled “10X Genomics Dominates the Single-Cell Landscape While Competitors Look for a Niche.” In that piece, DeciBio lists 11 co…
Calling A Bottom
- Another thing we’ve seen readers doing is trying to pick a bottom. Don’t. You’ll never successfully time the market, and there’s no reason to try when there are no transaction fees anymore for retail investors. Enter and exit positions slowly. Buy one share a day if you want. There’s no reason to try and call a bottom here. Maybe BLI has just been extremely overvalued, something we can ch…
Conclusion
- Making investment decisions for yourself won’t work unless you can act with conviction. Letting human emotion get in the way of investment decisions – like second-guessing yourself – means you will lose money and you won’t sleep well at night. We’re risk-averse investors who sleep well at night – and that’s not just because we’re all a bunch of borderline alcoholics. It’s because we …